Long-term efficacy and safety of rabeprazole in patients taking low-dose aspirin with a history of peptic ulcers: a phase 2/3, randomized, parallel group, multicenter, extension clinical trial

number of downloads : ?

Use this link to cite this item : https://ir.lib.shimane-u.ac.jp/53651

language	eng
Author	Fujishiro Mitsuhiro Department of Endoscopy and Endoscopic Surgery, Graduate School of Medicine, The University of Tokyo Higuchi Kazuhide Second Department of Internal Medicine, Osaka Medical College Kato Mototsugu Division of Endoscopy, Hokkaido University Hospital Kinoshita, Yoshikazu Iwakiri Ryuichi Department of Internal Medicine & Gastrointestinal Endoscopy, Saga Medical School Watanabe Toshio Department of Gastroenterology, Osaka City University Graduate School of Medicine Takeuchi Toshihisa Second Department of Internal Medicine, Osaka Medical College Sugisaki Nobuyuki Clinical Development, Japan/Asia Clinical Research Product Creation Unit, Eisai Product Creation Systems, Eisai Co., Ltd. Okada Yasushi Clinical Research Institute and Cerebrovascular Medicine, National Hospital Organization, Kyushu Medical Center Ogawa Hisao Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University National Cerebral and Cardiovascular Center Arakawa Tetsuo Department of Gastroenterology, Osaka City University Graduate School of Medicine Fujimoto Kazuma Department of Internal Medicine, Saga Medical School
Subject	low-dose aspirin; peptic ulcer; bleeding ulcer; serious adverse events; rabeprazole
Journal Title	JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
Volume	56
Issue	3
Start Page	228
End Page	239
ISSN	0912-0009
ISSN（Online）	1880-5086
Published Date	2015-05-1
DOI	10.3164/jcbn.15-1
PubMed ID	26060354
Publisher	JOURNAL CLINICAL BIOCHEMISTRY & NUTRITION
NII Type	Journal Article
OAI-PMH Set	Faculty of Medicine
Remark	The authors would like to thank all contributing members and the sponsor, Japan/Asia Clinical Research Product Creation Unit of Eisai Co., Ltd., Tokyo, Japan and the project members of Mediscience Planning Inc., Tokyo, Japan for their contribution to study monitoring.; This study was funded by Eisai Co., Ltd., Tokyo, Japan. Writing support was provided by Eisai. Data management and analyses were undertaken by Eisai.